-
1دورية أكاديمية
المؤلفون: Guoshuang Shen, Fuxing Zhao, Xingfa Huo, Dengfeng Ren, Feng Du, Fangchao Zheng, Jiuda Zhao
المصدر: Frontiers in Oncology, Vol 11 (2021)
مصطلحات موضوعية: human epidermal growth factor receptor 2 (HER2)-enriched subtype, HER2-postive breast cancer, neoadjuvant treatment, pathologic complete response, meta-analysis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2021.632357/fullTest; https://doaj.org/toc/2234-943XTest
-
2دورية أكاديمية
المؤلفون: Murphy, Jessica, Rani, Sweta
المصدر: SURE Journal: Science Undergraduate Research Experience Journal
مصطلحات موضوعية: Breast Cancer, HER2-postive Breast Cancer, Neuromedin U, Immediate Early Genes, Delayed Primary Response Genes, RT-PCR, Gene Expression Analysis, Cancer Biology, Life Sciences, Molecular Biology
وصف الملف: application/pdf
العلاقة: https://arrow.tudublin.ie/sure_j/vol1/iss1/3Test; https://arrow.tudublin.ie/context/sure_j/article/1008/viewcontent/SUREJ__1__MS1008_Murphy.pdfTest
الإتاحة: https://doi.org/10.21427/p04v-pf26Test
https://arrow.tudublin.ie/sure_j/vol1/iss1/3Test
https://arrow.tudublin.ie/context/sure_j/article/1008/viewcontent/SUREJ__1__MS1008_Murphy.pdfTest -
3صورة
المؤلفون: Guoshuang Shen (7902776), Fuxing Zhao (7902770), Xingfa Huo (10009053), Dengfeng Ren (7902779), Feng Du (288665), Fangchao Zheng (7902782), Jiuda Zhao (7902791)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, human epidermal growth factor receptor 2 (HER2)-enriched subtype, HER2-postive breast cancer, neoadjuvant treatment, pathologic complete response, meta-analysis
-
4صورة
المؤلفون: Guoshuang Shen, Fuxing Zhao, Xingfa Huo, Dengfeng Ren, Feng Du, Fangchao Zheng, Jiuda Zhao
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, human epidermal growth factor receptor 2 (HER2)-enriched subtype, HER2-postive breast cancer, neoadjuvant treatment, pathologic complete response, meta-analysis
الإتاحة: https://doi.org/10.3389/fonc.2021.632357.s001Test
https://figshare.com/articles/figure/Image_1_Meta-Analysis_of_HER2-Enriched_Subtype_Predicting_the_Pathological_Complete_Response_Within_HER2-Positive_Breast_Cancer_in_Patients_Who_Received_Neoadjuvant_Treatment_jpeg/15043485Test -
5
المؤلفون: Debora Fumagalli, Soizic Garaud, Cinzia Solinas, Marcello Ceppi, E. de Azambuja, Christos Sotiriou, Michail Ignatiadis, Mario Scartozzi, Laurence Buisseret, Matteo Lambertini, Karen Willard-Gallo, Roberto Salgado
المصدر: Cancer Treatment Reviews. 57:8-15
مصطلحات موضوعية: 0301 basic medicine, Oncology, Receptor, ErbB-2, HER2-postive breast cancer, medicine.medical_treatment, Tumor-infiltrating lymphocytes, ErbB-2, 0302 clinical medicine, Trastuzumab, Nuclear Medicine and Imaging, Pathologic complete response, Antineoplastic Combined Chemotherapy Protocols, Lymphocytes, skin and connective tissue diseases, Adjuvant, Neoadjuvant therapy, Randomized Controlled Trials as Topic, hemic and immune systems, General Medicine, Chemotherapy regimen, Neoadjuvant Therapy, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Radiology, Receptor, medicine.drug, Neoadjuvant treatment, medicine.medical_specialty, Anthracycline, Breast Neoplasms, chemical and pharmacologic phenomena, Lapatinib, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, Breast cancer, Internal medicine, medicine, Chemotherapy, Humans, Radiology, Nuclear Medicine and imaging, Tumor-Infiltrating, Quinazolines, Radiology, Nuclear Medicine and Imaging, Taxane, business.industry, medicine.disease, 030104 developmental biology, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af3425ffc5e3da4d918677080c6f3ad6Test
https://doi.org/10.1016/j.ctrv.2017.04.005Test -
6دورية أكاديمية
المؤلفون: Solinas, C, Ceppi, M, Lambertini, M, Buisseret, L, Garaud, S, Fumagalli, D, de Azambuja, E, Salgado, R, Sotiriou, C, Willard Gallo, K, Ignatiadis, M., SCARTOZZI, MARIO
المساهمون: Solinas, C, Ceppi, M, Lambertini, M, Scartozzi, Mario, Buisseret, L, Garaud, S, Fumagalli, D, de Azambuja, E, Salgado, R, Sotiriou, C, Willard Gallo, K, Ignatiadis, M.
مصطلحات موضوعية: HER2-postive breast cancer, Lapatinib, Neoadjuvant treatment, Pathologic complete response, Trastuzumab, Tumor-infiltrating lymphocytes
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28525810; info:eu-repo/semantics/altIdentifier/wos/WOS:000403423300002; volume:57; firstpage:8; lastpage:15; numberofpages:8; journal:CANCER TREATMENT REVIEWS; http://hdl.handle.net/11584/214621Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85019440425; http://www.sciencedirect.com/science/article/pii/S0305737217300634?via%3DihubTest
الإتاحة: https://doi.org/10.1016/j.ctrv.2017.04.005Test
http://hdl.handle.net/11584/214621Test
http://www.sciencedirect.com/science/article/pii/S0305737217300634?via%3DihubTest -
7دورية أكاديمية
المؤلفون: Solinas, Cinzia, Sotiriou, Christos, Willard-Gallo, Karen, Ignatiadis, Michail, Ceppi, Marcello, Lambertini, Matteo, Scartozzi, Mario, Buisseret, Laurence, Garaud, Soizic, Fumagalli, Debora, de Azambuja, Evandro, Salgado, Roberto
المصدر: Cancer treatment reviews, 57
مصطلحات موضوعية: Cancérologie, Imagerie médicale, radiologie, tomographie, Antineoplastic Combined Chemotherapy Protocols -- therapeutic use, Breast Neoplasms -- drug therapy -- enzymology -- immunology -- pathology, Chemotherapy, Adjuvant, Female, Humans, Lapatinib, Lymphocytes, Tumor-Infiltrating -- drug effects -- immunology -- pathology, Neoadjuvant Therapy, Quinazolines -- administration & dosage, Randomized Controlled Trials as Topic, Receptor, ErbB-2 -- antagonists & inhibitors -- biosynthesis, Trastuzumab -- administration & dosage, HER2-postive breast cancer, Neoadjuvant treatment, Pathologic complete response, Trastuzumab, Tumor-infiltrating lymphocytes
وصف الملف: 1 full-text file(s): application/pdf
العلاقة: uri/info:doi/10.1016/j.ctrv.2017.04.005; uri/info:pii/S0305737217300634; uri/info:pmid/28525810; uri/info:scp/85019440425; https://dipot.ulb.ac.be/dspace/bitstream/2013/253181/1/Elsevier_236808.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/253181Test
-
8مورد إلكتروني
المصدر: Cancer treatment reviews, 57
مصطلحات الفهرس: Cancérologie, Imagerie médicale, radiologie, tomographie, Antineoplastic Combined Chemotherapy Protocols -- therapeutic use, Breast Neoplasms -- drug therapy -- enzymology -- immunology -- pathology, Chemotherapy, Adjuvant, Female, Humans, Lapatinib, Lymphocytes, Tumor-Infiltrating -- drug effects -- immunology -- pathology, Neoadjuvant Therapy, Quinazolines -- administration & dosage, Randomized Controlled Trials as Topic, Receptor, ErbB-2 -- antagonists & inhibitors -- biosynthesis, Trastuzumab -- administration & dosage, HER2-postive breast cancer, Neoadjuvant treatment, Pathologic complete response, Trastuzumab, Tumor-infiltrating lymphocytes, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article